Fieldpoint Private Securities, LLC Bluebird Bio, Inc. Transaction History

Fieldpoint Private Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 23, 2021	SELL	$16.59 - $33.89 $19,161 - $39,142	-1,155 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$27.5 - $37.92 $31,762 - $43,797	1,155 New	1,155 $50,000
Q1 2020 May 11, 2020	SELL	$26.16 - $63.5 $65,243 - $158,369	-2,494 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$46.96 - $61.67 $71,942 - $94,478	1,532 Added 159.25%	2,494 $218,000
Q3 2019 Nov 07, 2019	SELL	$59.47 - $93.1 $4,936 - $7,727	-83 Reduced 7.94%	962 $88,000
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $79,252 - $109,944	1,045 New	1,045 $133,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.